The medical management of obesity is changing, thanks in part to new views on obesity and widespread adoption of weight-loss…
Browsing: Clinical Updates
Guardant Health has received FDA approval for its next-generation liquid biopsy platform, Guardant360 Liquid CDx, expanding the role of blood-based…
Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn’s disease and ulcerative colitis, affects about 1.6 million Americans, many…
Disorders of gut–brain interaction (DGBI), previously referred to as functional gastrointestinal disorders (FGID), have been poorly understood historically. Although providers…
DDW 2026 showcased several studies that may meaningfully influence upper GI clinical practice, particularly in Barrett’s esophagus, EoE, gastroparesis, pancreatitis,…
Picture a statistician in Oslo in 2009, working backward from a mortality assumption to calculate the sample size her trial…
MASH cirrhosis has traditionally been considered irreversible. However, new data from investigators at Cleveland Clinic, presented at Digestive Disease Week…
An experimental drug called daraxonrasib is generating major excitement in pancreatic cancer after early trials showed it could significantly extend…
The updated 13-year NordICC data showed that colonoscopy screening reduced colorectal cancer incidence by about 30%, strengthening the benefit seen…
Inflammatory bowel disease (IBD) presents unique challenges for older adults, particularly those in Medicare Advantage (MA) plans. In this population,…